Ipamorelin
Regulatory status by US jurisdiction. Reviewed and signed by a clinician. Not a dosing guide, not legal advice, and not a device.
Scriptura flags, alerts, and informs. The prescribing clinician makes every decision.
Federal posture
- Not FDA approved, compounding not eligible under 503A today.
- 503A bulks list: Under review by the Pharmacy Compounding Advisory Committee.
- DEA schedule: Not scheduled.
Status by jurisdiction
The verified date is the date the reviewer confirmed the status against public sources. It is not a state board confirmation. The prescribing clinician owns the compliance decision.
Reviewed and signed
Clinical review: Sabrina Runbeck, MPH, MHS, PA-C, Clinical Director, Scriptura Health, on 2026-07-22.
Subject matter: Sabrina Runbeck, MPH, MHS, PA-C, Clinical Director, Scriptura Health, on 2026-07-22.
Verified against public sources on 2026-07-24.
Get Scriptura in your clinic
See how Scriptura pulls federal, state, and clinical sources into one reviewed view for prescribing clinicians. Book a live walkthrough, or get short updates when the rules move.
Reviewed by Sabrina Runbeck, MPH, MHS, PA-C, Clinical Director, Scriptura Health.